NU/1246-7 MAGNITUDE BIOSCIENCES Commercialisation of university research through provision of management skills to assist in successful spin-out company creation
What the buyer wrote
Magnitude Biosciences intends to be a significant player in the current world-wide endeavor to understand aging and assist companies and academic researchers create new drugs and food additives that promote healthspan (healthspan is the active period of a lifetime). This research field is receiving very significant attention from the investor community. Ageing Research, however, faces a significant practical challenge because to properly assess the impact of a compound on aging and healthspan, very large test populations are required to capture the inherent variability of aging in that population. An initial investment will enable Magnitude Biosciences to engage with the market to sec…
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- NU/1246-7 MAGNITUDE BIOSCIENCES Commercialisation of university research through provision of management skills to assist in successful spin-out company creation
- How they are buying
- The buyer did not say
- Type
- services
- Suitable for small firms
- The buyer says yes. What that is worth
- Work starts
- 1 Feb 2018
- Work ends
- 31 Dec 2018
- Kind of work
- Accountancy, audit and financial advice
Who the buyer named
Leigh Anderson was the named contact on this notice.